DermTech, Inc. Common Stock
DMTK
DMTK was delisted on the 26th of June, 2024.
176 hedge funds and large institutions have $845M invested in DermTech, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 76 increasing their positions, 30 reducing their positions, and 40 closing their positions.
153% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 30
18% more first-time investments, than exits
New positions opened: 47 | Existing positions closed: 40
4% more funds holding
Funds holding: 169 → 176 (+7)
7% less call options, than puts
Call options by funds: $16.9M | Put options by funds: $18.1M
17% less capital invested
Capital invested by funds: $1.01B → $845M (-$169M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$27.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$19.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.4M |
| 4 |
Two Sigma Investments
New York
|
+$10.2M |
| 5 |
FAM
Fred Alger Management
New York
|
+$8.74M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
ISZO Capital Management
New York
|
-$30.1M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$14.4M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$12.5M |
| 4 |
PCM
Parsifal Capital Management
Greenwich,
Connecticut
|
-$11.2M |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$10.4M |
DMTK Hedge Fund Activity: Q2 2021 in Review
176 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q2 2021, worth a combined $845M — down 17% from $1.01B a quarter earlier.
Buyers outnumbered sellers: 47 funds opened new DMTK positions and 40 closed out — a net gain of 7 holders — while 76 added to existing stakes and 30 trimmed.
The largest buyer was BlackRock, adding an estimated $27.8M. The largest seller was ISZO Capital Management, cutting an estimated $30.1M.
- 176 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q2 2021, up from 169 in Q1 2021.
- Funds reported $845M of DermTech, Inc. Common Stock stock for Q2 2021, down 17% quarter-over-quarter.
- 47 funds opened new DermTech, Inc. Common Stock positions in Q2 2021 and 40 closed out, a net change of +7 holders.
- The largest DermTech, Inc. Common Stock buyer in Q2 2021 was BlackRock, an estimated $27.8M added.
- The largest DermTech, Inc. Common Stock seller in Q2 2021 was ISZO Capital Management, an estimated $30.1M sold.
Based on aggregated 13F filings for Q2 2021.